Organon Pharma Indonesia Tbk. vs Tempo Intimedia Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Tempo Intimedia Tbk. trades at Rp151 (market cap 168.27B, 13.5M 24h volume). The key difference: Tempo Intimedia Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| SCPI | TMPO | |
|---|---|---|
Market Cap | 104.4B | 168.27B |
Volume | — | 13.5M |
Lot | — | 135K |
Turnover | — | 2.05B |
Average Price | — | 151.71 |
Value | — | 2.05B |
Indicative Equilibrium Price | — | 151 |
Indicative Equilibrium Volume | — | 1.54K |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →PT Tempo Inti Media Tbk (the Company) was established under its origin name of PT Arsa Raya Perdana on August 27, 1996 , based on deed No.77 of notary Sulaimansjah, SH. The Company’s articles of association has been amended from time to time, the latest of which was drawn up in notarial deed No.49 dated Sept 29, 2000 of Fathiah Helmi, S.H., relating to, among others, the change of company's name, the increase in authorized and issued capital of the Company in connection with the first offering, and stock split.
Read more on TMPO →